Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

作者：Philippe Merle, Jean‐Frédéric Blanc, Jean–Marc Phelip, Gilles Pelletier, Jean–Pierre Bronowicki, Yann Touchefeu, Georges‐Philippe Pageaux, René Gerolami, François Habersetzer, Éric Nguyen-Khac, Andrea Casadei‐Gardini, Ivan Borbath, Albert Tran, Henning Wege, Amr S. Saad, Massimo Colombo, Armand Abergel, Carine Richou, Imam Waked, Nelson S. Yee, Audrey Molé, P Attali, Julie Le Boulicaut, B. Vasseur, Driffa Moussata, Jean‐Didier Grangé, Vlad Ratziu, Faiza Khemissa-Akouz, Hélène Regnault, Barbara Dauvois, Jean‐Pierre Zarski, Isabelle Ollivier‐Hourmand, Sylvain Manfrédi, Marilyne Debette‐Gratien, Alice Gangloff, Thierry Fontanges, Aurore Baron, Mohamed Bouattour, Julie Vincent, Wolfgang Sieghart, A Maieron, Marc Peeters, Jean Delwaide, Luc Lasser, Thomas Berg, Michael Schultheiß, Alexander Zipprich, Joerg Trojan, Ursula Ehmer, Gabriele Luppi, Giovanni Luca, Stefano Tamberi, D. Amoroso, Oscar Alabiso, Angela Buonadonna, Pierluigi Toniutto, Emiliano Tamburini, Antonio Cubillo, Andrés Muñoz, Carmen Guillén, Gloria Sánchez, Hermini Manzano, Vı́ctor Navarro, Inmaculada Alés, Bartomeu Massutí, Magdolna Dank, G. Bodoky, Zsuzsanna Kahán, Zsolt Horváth, Nashat Gabrail, Howard Ozer, Christos Galanopoulos, Ralph J. Hauke, Moses S. Raj, Hakan Harputluoğlu, Alper Sevinç, Erdem Göker, Ahmet Çöker, Şuayib Yalçın, Muhammet Ali, Özlem Ata, Ilkay Tugba, Mohammed El Kassas, Amr Abdel, Imam Wakid, Sameh Shamaa, Nasr El Lahlouby, Hanaa M Kohail, Jawad A. Makarem, Issam Chehade, Fadi Farhat, Carlos López, Miguel Marín · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2019 · DOI：10.1016/s2468-1253(19)30040-8 · 被引用次数：61 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Nanoparticle-Based Drug Delivery、Curcumin's Biomedical Applications